- Tags: myopia
Events
The Myopia Collective adds Student Change Agent advocates to nationwide initiative
Students from the nation's top optometry school join a new cohort of Change Agents as TMC hosts first-ever Day of Advocacy during Optometry's Meeting.
Research
Atropine taper leads to less pediatric myopia progression
Long-term randomized data supports a gradual taper before discontinuation, demonstrating a reduced rebound myopia progression in children.
Research
CooperVision completes global enrollment for largest pediatric myopia control study
Post-approval studies in the U.S. and China will provide real-world evidence on the efficacy of MiSight 1 day in managing myopia.
Business
Myopia Focus launches customizable patient education tools for ECP websites
UK-based initiative’s Tool Creator enables clinical practice to create and embed interactive education tools directly into their digital interfaces.
Pipeline
New SightGlass 24-month data shows DOT lenses significantly slow pediatric myopia progression
Unveiled at ARVO 2026, DOT lenses saved more than 1 D of myopic progression on average after 2 years among 6-to-10-year-old wearers.
Research
Breakthrough trial finds MiYOSMART iQ spectacle lenses halt childhood myopia progression
Latest 12-month data details highest myopia-control efficacy results reported to date in myopes as young as age 4 wearing HOYA’s D.I.M.S. technology.
Business
Leadership watch: Updates from Nanoscope, Topcon, Tenpoint, and TheiaLife
Leadership changes are underway in the eyecare space—and we’ve got the latest.
Research
Researchers question safety of red light among pediatric myopes
Laboratory analysis suggests some devices may exceed established retinal safety limits during recommended treatment times.
Research
Study links poor diet with increased pediatric myopia
Cross-sectional study finds diets heavy in processed and sugar foods increase risk, while those rich in nuts, legumes, and whole grains appear protective.
Pipeline
Sydnexis's low-dose atropine shows strong phase 3 efficacy for pediatric myopia
Recent 3-year data from the STAR trial meets primary and secondary endpoints for SYD-101, including the greatest treatment benefits among younger myopes.
Events
Registration opens for Eyes On Myopia 2026
Virtual event kicks off May 9 in partnership with Woo University, offering up to 5 hours of COPE-accredited CE credits.
Research
High myopes face increased PCO risk with hydrophilic IOLs
Study finds hydrophobic IOLs reduced the risk of PCO in highly myopic eyes by 41%.
Research
Lutein shows potential as myopia management supplement
Preliminary RCT data highlights preservation of choroidal thickness in children taking lutein supplements.
Research
HOYA reports 6-month data on MiYOSMART iQ spectacle lenses for pediatric myopia
Interim results find advanced lens and D.I.M.S. triple enhanced design tech to be twice as effective in controlling axial elongation and disease progression.
Research
Conflicting evidence surrounds astigmatism's role in myopia
Study highlights need for further investigation into the impact of astigmatism on myopia onset and progression.
Products
Euclid Vision launches new SiHy daily disposable lens for myopia
The Be Free Day soft lens for pediatric myopes features BHVI's proprietary dual action, multistep optical design technology.
Research
Research finds limited benefits of outdoor exposure for premyopic children
Protective effect of time outdoors observed in hyperopes and premyopic children after spending >120 minutes/day outside.
Research
Essilor Stellest 2.0 lenses demonstrate superior efficacy in slowing myopia progression
Upgraded FDA-authorized spectacle lenses for pediatric myopia control found to slow axial elongation more effectively after 1 year with advanced technology.
Pipeline
Sydnexis reports phase 3 topline data on SYD-101 eye drop for pediatric myopia
The STAR study met both primary and secondary endpoints for low-dose atropine formulation—just days after the FDA’s NDA rejection.
Research